LT3169311T - Pediatriniai milteliai geriamajai suspensijai, turintys antivirusinį agentą ir jų gavimo būdas - Google Patents

Pediatriniai milteliai geriamajai suspensijai, turintys antivirusinį agentą ir jų gavimo būdas

Info

Publication number
LT3169311T
LT3169311T LTEPPCT/EP2015/001239T LTEP2015001239T LT3169311T LT 3169311 T LT3169311 T LT 3169311T LT EP2015001239 T LTEP2015001239 T LT EP2015001239T LT 3169311 T LT3169311 T LT 3169311T
Authority
LT
Lithuania
Prior art keywords
preparation
suspension containing
antiviral agent
oral suspension
containing antiviral
Prior art date
Application number
LTEPPCT/EP2015/001239T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthymios Koutris
Vasiliki SAMARA
Ioanna Koutri
Anastasia Kalaskani
Lida Kalantzi
Andreas KAKOURIS
Amalia DIAKIDOU
George GOTZAMANIS
Zaharias GEORGOUSIS
Manolis FOUSTERIS
Original Assignee
Pharmathen S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen S.A. filed Critical Pharmathen S.A.
Publication of LT3169311T publication Critical patent/LT3169311T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/EP2015/001239T 2014-07-17 2015-06-19 Pediatriniai milteliai geriamajai suspensijai, turintys antivirusinį agentą ir jų gavimo būdas LT3169311T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2014001951 2014-07-17
PCT/EP2015/001239 WO2016008560A1 (en) 2014-07-17 2015-06-19 Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof

Publications (1)

Publication Number Publication Date
LT3169311T true LT3169311T (lt) 2023-10-25

Family

ID=53483765

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2015/001239T LT3169311T (lt) 2014-07-17 2015-06-19 Pediatriniai milteliai geriamajai suspensijai, turintys antivirusinį agentą ir jų gavimo būdas

Country Status (13)

Country Link
US (1) US11969429B2 (lt)
EP (2) EP4134070A1 (lt)
DK (1) DK3169311T3 (lt)
ES (1) ES2960705T3 (lt)
FI (1) FI3169311T3 (lt)
HR (1) HRP20231364T1 (lt)
HU (1) HUE063821T2 (lt)
LT (1) LT3169311T (lt)
PL (1) PL3169311T3 (lt)
PT (1) PT3169311T (lt)
RS (1) RS64688B1 (lt)
SI (1) SI3169311T1 (lt)
WO (1) WO2016008560A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113060723B (zh) * 2021-03-18 2022-11-04 上海健康医学院 纳米银氨基修饰的还原氧化石墨烯框架材料及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
EP2018160B1 (en) * 2006-03-16 2011-12-14 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
EP2197424A2 (en) * 2007-10-17 2010-06-23 Pharmathen S.A. Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
US20090202635A1 (en) * 2008-02-08 2009-08-13 Stephen Michael Scott Delivery System, Application, and Method
US20120093738A1 (en) * 2009-06-11 2012-04-19 Rubicon Research Private Limited Taste-masked oral formulations of influenza antivirals
AU2010337856A1 (en) * 2009-12-31 2012-07-19 Ranbaxy Laboratories Limited Taste masked dosage forms of bitter tasting anti-retroviral drugs
US20120149720A1 (en) * 2010-07-30 2012-06-14 Ranbaxy Laboratories Limited Valacyclovir formulations

Also Published As

Publication number Publication date
SI3169311T1 (sl) 2023-12-29
PL3169311T3 (pl) 2024-01-15
RS64688B1 (sr) 2023-11-30
HRP20231364T1 (hr) 2024-02-16
EP3169311B1 (en) 2023-08-02
US11969429B2 (en) 2024-04-30
EP4134070A1 (en) 2023-02-15
HUE063821T2 (hu) 2024-02-28
WO2016008560A1 (en) 2016-01-21
US20170202843A1 (en) 2017-07-20
PT3169311T (pt) 2023-10-11
FI3169311T3 (fi) 2023-11-01
EP3169311A1 (en) 2017-05-24
DK3169311T3 (da) 2023-10-30
ES2960705T3 (es) 2024-03-06

Similar Documents

Publication Publication Date Title
HRP20190397T1 (hr) Jednodozni inhalator s prahom i postupak njegove proizvodnje
HK1254055A1 (zh) 製備奧貝膽酸及其衍生物的方法
HK1244808A1 (zh) 苯並哌啶類衍生物、其製備方法及其在醫藥上的應用
IL259910A (en) Nicotine particle capsule
HK1246656A1 (zh) 含有伊立替康的口服固體製劑及其製備方法
IL256067B (en) System of multiple bags and method for preparing blood components
ZA202002088B (en) Acetate powder and method for the preparation thereof
ZA202002073B (en) Lactate powder and method for the preparation thereof
HRP20181919T1 (hr) Pedijatrijska tableta za žvakanje koja sadrži antivirusni agent i postupak pripreme iste
SI3169311T1 (sl) Pediatrični prah za oralno suspenzijo, ki vsebuje protivirusno sredstvo in postopek za njegovo uporabo
HK1232209A1 (zh) 製備 -乙酰氧基丙酸及其衍生物的方法
IL253174A0 (en) Nanoparticles and methods for their preparation
EP3131546A4 (en) Oral rapamycin preparation and use for stomatitis
GB201506618D0 (en) Oral suspension
SG11201608653YA (en) Preparation method for high-purity 4'-galactosyl-lactose composition